Skip to main content

Psoriatic Arthritis News

Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis

WEDNESDAY, April 30, 2025 – Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA), according to a study published online March 29 in...

Psoriatic Arthritis Diagnoses Are Lagging, Patients Undertreated

FRIDAY, April 18, 2025 – It’s taking too long for people with psoriatic arthritis to be diagnosed and treated, a new study argues. Visible signs of psoriatic arthritis appear months and even years b...

FDA Approves Steqeyma (ustekinumab-stba), a Biosimilar to Stelara

JERSEY CITY, N.J., Dec. 17, 2024 – Celltrion announced today that the U.S. Food and Drug Administration (FDA) has approved Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), for...

FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara

Bengaluru, Karnataka, India, December 01, 2024 -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced ...

American College of Rheumatology, Nov. 14-19

The annual meeting of the American College of Rheumatology was held this year from Nov. 14 to 19 in Washington, D.C., and attendees included rheumatology specialists, physicians, scientists, and o...

FDA Approves Imuldosa (ustekinumab-srlf), a Biosimilar to Stelara

RALEIGH, N.C., Oct. 14, 2024 /PRNewswire/ – Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care...

FDA Approves Otulfi (ustekinumab-aauz), a Biosimilar to Stelara

September 30, 2024 – Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic...

UCB announces U.S. FDA approvals for Bimzelx (bimekizumab-bkzx) for the treatment of psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis

Brussels (Belgium), September 23, 2024 – 07:00 (CEST) – UCB, a global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Bimzelx (bi...

FDA Approves Bimzelx for Three New Indications

THURSDAY, Sept. 26, 2024 – The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active n...

Psoriasis, Psoriatic Arthritis Tied to Higher Risk of Polyneuropathy

MONDAY, July 29, 2024 – Psoriasis and psoriatic arthritis may be associated with an increased risk of polyneuropathy, according to a study published online June 28 in Muscle & Nerve. Pietro E. ...

Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue

MONDAY, July 1, 2024 – Psoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American...

FDA Expands Pediatric Indication for Rinvoq

FRIDAY, June 21, 2024 – The U.S. Food and Drug Administration has expanded indications for Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular...

Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights

MONDAY, May 13, 2024 – Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal...

FDA Approves Selarsdi (ustekinumab-aekn), a Biosimilar to Stelara

REYKJAVIK, Iceland & PARSIPPANY, N.J.--(BUSINESS WIRE) April 16, 2024 --Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...

FDA Approves Simlandi (adalimumab-ryvk), an Interchangeable Biosimilar to Humira

REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 24, 2024 (GLOBE NEWSWIRE) – Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Spondyloarthritis

Related drug support groups

prednisone, methotrexate, Humira, triamcinolone, cortisone, Enbrel, Stelara, Remicade, Otezla, view more... Xeljanz, Cosentyx, Skyrizi, dexamethasone, adalimumab, etanercept, ustekinumab, Cimzia, Taltz